What is DSIP? The original delta sleep-inducing peptide
The sequence is known. The biological identity is much harder to pin down.
The rabbit experiment
Schoenenberger and Monnier characterized DSIP in 1977 after isolating it from cerebral venous blood in rabbits during electrically induced sleep. Infusing it into the brain's fluid-filled spaces enhanced delta and spindle EEG activity. EEG is the recording of electrical activity in the brain; delta refers to the slow waves that gave DSIP its name.
There is something wonderfully specific about that beginning. I pictured a general search for a sleeping medicine. The actual starting point was an experimental state in rabbits, a substance recovered from blood and a change in an electrical recording. Those circumstances matter to the identity of the finding.
The peptide's sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, also written WAGGDASGE. Nine amino acids make it a nonapeptide. That chemical description is considerably firmer than the familiar claim that DSIP is the body's sleep signal.
Original DSIP and the altered forms
Original DSIP is the parent sequence. Papers also discuss a phosphorylated form, with a phosphate group attached, and synthetic analogues whose structure has been changed. The 2006 review found that artificial analogues often produced the clearest sleep effects. I regard the exact molecule tested as essential information whenever a sleep claim sounds impressive.
The distinction becomes especially concrete in the 2024 fusion-peptide study. Researchers joined DSIP to a peptide designed to help it cross the blood-brain barrier, the selective boundary between circulating blood and brain tissue. The engineered fusion outperformed unmodified DSIP in mice with experimentally induced insomnia. Those are separate test substances, with separate results.
Emideltide is another name for DSIP itself. It does not identify an approved drug product. The name supplies an identity; the treatment evidence still has to come from experiments.
Delta sleep-inducing peptide: mechanism of action
A receptor is the molecular site through which a signal can act on a cell. DSIP's specific receptor remains unidentified, as do its gene and a larger precursor protein. Kovalzon and Strekalova also questioned how its brain distribution fitted sleep regulation. Several proposed actions involve stress hormones, dopamine, serotonin or cellular responses to low oxygen, without producing a settled account of DSIP's normal role.
The proposed actions still leave the core sleep relationship unresolved. Predicting interactions from that incomplete account is difficult.
The research record includes the human hormone result and the mouse work. The study amounts page takes up another complication: some experimental effects weakened as the amount increased.
The surprising signal from the gut
A study of gut endocrine cells in people, pigs and rats found DSIP-like immunoreactivity, with the human gut the richest source in that comparison. Immunoreactivity means an antibody test reacted with material resembling DSIP. It leaves room for related material to account for the signal.
In human midgut carcinoid tumour cells and cultures, investigators also found DSIP-like peptides alongside serotonin. They concluded that DSIP had not proved clinically useful as a tumour marker.
The ambiguous tissue tests intrigue me; a neat tissue catalogue would lose precisely what makes them interesting. A chemical sequence can be established while the identity and purpose of the material detected in tissue remain unsettled. Here the cautious wording in the tissue papers does real work.